Promoting Aerobic Training in Multiple Sclerosis
Aerobic Training as Substrate for Neural Plastic Changes in Multiple Sclerosis: a Putative Disease-modifying Treatment?
1 other identifier
interventional
62
1 country
1
Brief Summary
Multiple sclerosis (MS) is a chronic neurological disease characterized by inflammation and degeneration within the central nervous system. Over the course of the disease, most patients with MS successively accumulate inflammatory lesions and axonal damage with an increasing degree of disability. Thus, pharmacological treatment options are currently adopted to limit inflammation and to decrease the relapse rate, or simply to alleviate symptoms. On the other hand, neurorehabilitation aims to maintain and possibly improve the residual capacities of neurological patients in order to preserve personal and social activities, constituting an important part of quality health care for MS patients. However, to date, there is no definite agreement on which specific exercise therapy program can be considered the most successful in improving activities and participation. Several studies suggest that a training based on voluntary movements produces greater improvements than a passive treatment. Aerobic exercise training has been also shown to have significant neurophysiological effects in different populations. Furtherly, sports activity may increase adherence and motivation, especially in a young population such as the MS community. However, feasibility of sports activity has not been investigated yet and, in general, the potential interest of these approaches for MS patients remains to determine. This study aims at promoting physical activity in people with MS. Specific objectives are: (i) to evaluate the motor behavioral and neural changes induced by aerobic exercise combined with upper limb motor training based on task-oriented exercises; (ii) to assess the feasibility of leisure time physical activity (e.g. water sports activities) largely involving upper limb function. Participants will receive task-oriented treatment, but only the experimental group will perform also aerobic training in order to evaluate the effect of aerobic exercise. Moreover, the role of sports activities will be preliminary investigated, by promoting the participation of the included patients to local or national events focusing on adapted aerobic sports specifically involving upper limb function (e.g., water sports such as sailing, windsurfing, canoeing). Clinical measures will be performed before and after interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Jan 2018
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 2, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2023
CompletedJanuary 28, 2022
January 1, 2022
5.5 years
November 2, 2021
January 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the 6 minute walk test (6mWT) performance
The 6mWT assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance
Baseline (T0), after 5 days of sports activity (Ti, if applicable), after 8 weeks (T1), after 16 weeks (T2)
Secondary Outcomes (17)
Change in the Timed 25-Foot Walk test (T25FW) performance
Baseline (T0), after 5 days of sports activity (Ti, if applicable), after 8 weeks (T1), after 16 weeks (T2)
Change in the Nine Hole Peg Test (NHPT) performance
Baseline (T0), after 5 days of sports activity (Ti, if applicable), after 8 weeks (T1), after 16 weeks (T2)
Change in the Modified Fatigue Impact Scale (MFIS) score
Baseline (T0), after 5 days of sports activity (Ti, if applicable), after 8 weeks (T1), after 16 weeks (T2)
Change in the Short Form Health Survey (SF-36) score
Baseline (T0), after 5 days of sports activity (Ti, if applicable), after 8 weeks (T1), after 16 weeks (T2)
Structural and functional plasticity of the Central Nervous System (CNS)
Baseline (T0), after 8 weeks (T1), after 16 weeks (T2)
- +12 more secondary outcomes
Study Arms (2)
Aerobic Exercise Promotion
EXPERIMENTALThis group will be submitted to an aerobic exercise program combined with upper-limb motor training.
Control
ACTIVE COMPARATORThis group will be submitted to a standard motor rehabilitation. No aerobic nor sport activity will be delivered to the Control group.
Interventions
Interventions will be delivered through twenty supervised 40-minutes aerobic sessions (3 times a week). Patients will be trained on a bicycle ergometer (5-minute warm-up, 30 minute of intense training, 5-minute cool-down). Warm-up will be performed at the 30% of the maximal heart rate, while training will be performed at the 50-70% of the maximal heart rate as recommended by the general guidelines for aerobic exercise training specific for MS. Actual heart rate will be constantly monitored by a wearable heart rate monitor.
The training will consist in twenty 1-hour sessions (3 times a week) of exercises for neuromuscular control to improve proprioceptive sensibility, muscle strength, stability and coordination of the upper limbs, including unimanual and bimanual task-oriented exercises.
A subgroup of participants will also be involved in events promoting sports activity including both aerobic and task-oriented exercises (e.g., water sports such as sailing, windsurfing, canoeing) in order to evaluate their potential role to increase adherence to training, participation and quality of life.
Eligibility Criteria
You may qualify if:
- Multiple sclerosis diagnosis according to McDonald criteria
- relapsing-remitting course
- absence of relapses in the last three months
- an Expanded Disability Status Score (EDSS) ≤ 4
You may not qualify if:
- steroid-use, psychiatric disorders or severe cognitive impairment
- acute cardio-respiratory diseases
- magnetic resonance imaging contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Italiana Sclerosi Multiplalead
- Universita degli Studi di Genovacollaborator
- University Grenoble Alpscollaborator
Study Sites (1)
Italian Multiple Sclerosis Association and Foundation
Genoa, GE, 16149, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giampaolo Brichetto, MD, PhD
Italian Multiple Sclerosis Association and Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2021
First Posted
January 28, 2022
Study Start
January 1, 2018
Primary Completion
June 24, 2023
Study Completion
December 25, 2023
Last Updated
January 28, 2022
Record last verified: 2022-01